BSc.(Hons) 1st Class Chemistry, University of Kent, UK, 1971.
PhD Pharmacology, Clare College, University of Cambridge, UK, 1975.
University of Kent, United Kingdom, BSc(Hons) 1st Class Chemistry 1971.
University of Cambridge, United Kingdom, PhD Pharmacology 1975.
Department of Pharmacology, University of Cambridge, Science Research Council Fellow 1975-1977.
Department of Pharmacology, University of Cambridge, Medical Research Council Fellow, 1978-1980.
Senior Scientist, Peter MacCallum Cancer Institute, Melbourne, 1981-1989.
Professor of Cancer Research, University College Dublin, 1990-1997.
Visiting Fellow, School of Chemistry, UNSW, 1998.
Associate Professor, School of Medical Sciences, UNSW, 1999-2019.
Appointed Honorary Associate Professor, School of Chemistry, UNSW, April 2019.
Total funds of $A3.5 million (at contemporary values) for studies of DNA-directed anti-cancer drugs. Sources include the UK Science Research Council, the UK Medical Research Council, the Australian Research Council, the Australian National Health and Medical Research Council, the Irish Research Council, the Irish Health Research Board, the Anti-Cancer Council of Victoria, the Association for International Cancer Research Scotland, and Cure Cancer Australia.